AVP and myocardial infarction: Assessment of cardiac troponins will continue to be the gold standard for excluding myocardial infarction, but a strategy of assessing both troponins and copeptin appears to be more likely to effectively exclude acute myocardial infarction than measuring troponins alone [79,80,81].